Ann: Appendix 4C and Market Update, page-12

Good observations Triage.
Re: your comment about 3rd parties. My understanding is that "3rd parties" like Sonic, ACL etc etc. do the pathology testing on behalf of Govt. agencies and the likes of specialists etc.
I wouldn't expect RHY to be working directly with Govt., except to obtain TGA approval of course.
They seem to have a fairly strong line into Sonic and perhaps that's where the focus should/will be in locking in a partner.
Totally agree that some sort of commercialisation Agreement, even an MOU at this stage, would be an extremely positive sign. I think we'll see a turnaround by October - its longer than I want but I think another six months is likely.
I'm mildly confident in Otto... he has a reasonable track record and good contacts in the industry, plus a pretty strong BoD. Again, the next 6 months will tell.
It looks like a great product and all the (repeatable, consistent)) test results to date lead one to think that its eventually going to get TGA approval. Maybe its the test kits, not the product, that weren't able to be approved... who knows... I can only assume RHY aren't able to share more than they have to date, as frustrating as that is to us on the sidelines.
Personally... I think its a good opportunity to buy (for new investors) but I'm currently well underwater and I have a rule that I don't average down.
GLTAH